Open original FDA record ↗Recall record
- FDA identifier
- Z-0401-2017
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc.
- FDA record creation date
- Nov 11, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
Siemens Healthcare Diagnostics has become aware of deferoxamine interference with Dimension and Dimension Vista IRON assays at a different concentration than listed in the Instructions for Use (IFU).
Source facts
- Action
- Siemens mailed an Urgent Medical Device Correction letter to all customers who received the Dimension and Dimension Vista IRON Flex reagent with an update to the Limitation of Procedure section for the Dimension and Dimension Visa IRON assays Instructions For Use (IFU) to indicate that: patients treated with metal-binding drugs (e.g. deferoxamine) may have depressed iron values, as chelated iron may not properly react in the iron assay. Customers were told that the information provided in the letter, related to deferoxamine, supersedes the information related to deferoxamine int he current IRON IFU's for Dimension and Dimension Vista products until the IFU's are updated.
- Initiated
- 2016-08-25
- Root cause
- Error in labeling
- Terminated
- 2017-12-01
- Distribution
- Distributed Nationwide
- Recall number
- Z-0401-2017
- Recall status
- Terminated
- CDRH record ID
- 149809
- FDA record created
- 2016-11-11
- Recall event number
- 75256